These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 9661069)

  • 1. Paget's disease of bone.
    Siris ES
    J Bone Miner Res; 1998 Jul; 13(7):1061-5. PubMed ID: 9661069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
    Siris ES; Lyles KW; Singer FR; Meunier PJ
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P94-8. PubMed ID: 17229018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Paget's disease of bone.
    Langston AL; Ralston SH
    Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget's disease of bone--current thinking and management.
    Hughes S; Peel-White AL; Peterson CK
    J Manipulative Physiol Ther; 1992 May; 15(4):242-9. PubMed ID: 1321871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
    Stuckey BG; Lim EM; Kent GN; Ward LC; Gutteridge DH
    J Bone Miner Res; 2001 Sep; 16(9):1719-23. PubMed ID: 11547843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Paget's disease of bone: nonlinkage to the PDB1 and PDB2 loci on chromosomes 6p and 18q in a large pedigree.
    Good D; Busfield F; Duffy D; Lovelock PK; Kesting JB; Cameron DP; Shaw JT
    J Bone Miner Res; 2001 Jan; 16(1):33-8. PubMed ID: 11149487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone.
    Cremers SC; Eekhoff ME; Den Hartigh J; Hamdy NA; Vermeij P; Papapoulos SE
    J Bone Miner Res; 2003 May; 18(5):868-75. PubMed ID: 12733726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate.
    O'Doherty DP; Bickerstaff DR; McCloskey EV; Hamdy NA; Beneton MN; Harris S; Mian M; Kanis JA
    J Bone Miner Res; 1990 May; 5(5):483-91. PubMed ID: 2195845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR; Minoofar PN
    Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE
    Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease.
    Friedrichs WE; Reddy SV; Bruder JM; Cundy T; Cornish J; Singer FR; Roodman GD
    J Bone Miner Res; 2002 Jan; 17(1):145-51. PubMed ID: 11771661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
    Hosking D; Lyles K; Brown JP; Fraser WD; Miller P; Curiel MD; Devogelaer JP; Hooper M; Su G; Zelenakas K; Pak J; Fashola T; Saidi Y; Eriksen EF; Reid IR
    J Bone Miner Res; 2007 Jan; 22(1):142-8. PubMed ID: 17032148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for improved therapeutic strategy in patients with Paget's osteitis deformans].
    Ringe JD; Reginster JY; Gennari C; Hosking DJ; Meunier PJ
    Z Rheumatol; 1996; 55(4):256-9. PubMed ID: 8967186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of Paget's disease].
    Kurth AA
    Orthopade; 2007 Feb; 36(2):118, 120-3. PubMed ID: 17252256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paget's disease of bone: diagnosis and treatment update.
    Noor M; Shoback D
    Curr Rheumatol Rep; 2000 Feb; 2(1):67-73. PubMed ID: 11123042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Paget's disease based on viral etiology.
    Mirra JM
    Clin Orthop Relat Res; 1987 Apr; (217):162-70. PubMed ID: 3549089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.